Nanoparticle-mediated dual delivery of resveratrol and DAP5 ameliorates kidney ischemia/reperfusion injury by inhibiting cell apoptosis and inflammation

Yong Xu, Bo Zhang, Da Xie, Yu Hu, Hailun Li, Lili Zhong, Hongwu Wang, Wei Jiang, Zun‐Ping Ke, Donghui Zheng

Oncotarget · 2017 · 31 citations · 19 references

DOIFull text

Open access

Concepts

Abstract

// Yong Xu 1, * , Bo Zhang 2, * , Da Xie 3, * , Yu Hu 1 , Hai-Lun Li 1 , Li-Li Zhong 1 , Hong-Wu Wang 1 , Wei Jiang 1 , Zun-Ping Ke 4 and Dong-Hui Zheng 1 1 Department of Nephrology, The Affiliated Huai’an Hospital of Xuzhou Medical University and The Second People’s Hospital of Huai’an, Huai’an, China 2 Department of Dermatology, Hubei Provincial Hospital of TCM, Hongshan, Wuhan, China 3 Department of Nephrology, The Secend Affiliated Hospital of Nanjing Medical University, Nanjing, China 4 Department of Cardiology, The Fifth People’s Hospital of Shanghai, Fudan University, Shanghai, China * These authors have contributed equally to this study and share first authorship Correspondence to: Dong-Hui Zheng, email: zddwjj@126.com Zun-Ping Ke, email: kzprenmin@163.com Keywords: Res-DAP5 nanoparticles, apoptosis, inflammation, ischemia-reperfusion, acute renal injury Received: December 01, 2016     Accepted: February 12, 2017     Published: April 17, 2017 ABSTRACT Ischemia reperfusion (I/R) injury is a leading cause of acute kidney injury with high morbidity and mortality due to limited therapy. NMDA receptor inhibitor (DAP5) and resveratrol (Res) could ameliorate kidney I/R injury, but their use is limited by low aqueous solubility and poor stability. Here, we examined the potential protective effects of Res-DAP5 nanoparticles (NP) against renal I/R injury. Mice were subjected to renal ischemia for 30 min followed by reperfusion for 24 h. The results showed that Res-DAP5-NP could decreased serum creatinine (Cr) and urea nitrogen (BUN), alleviated tubular damage and oxidative stress. In addition, Res-DAP5-NP suppressed cell apoptosis, promoted the expression of p-DAPK, and inhibited the expression of p-CaMK and p-AKT. Furthermore, Res-DAP5-NP decreased the production of pro-inflammatory cytokines such as tumor necrosis factor-α, IL-1β, IL-6, and p-IκBα induced by renal I/R injury. In addition, Res-DAP5-NP also attenuated renal I/R injury in vivo , as manifested by increase in cell viability, SOD level, and the expression of p-DAPK, decreases in intracellular Ca 2+ concentration and the expression of p-CaMK. Taken together, our findings indicates that Res-DAP5-NP could effectively protect renal I/R injury by inhibiting apoptosis and inflammation responses, possibly through AKT/NMDA/CaMK/DAPK and NF-κB pathways.

References

19